UBS Initiates Coverage On Constellium with Buy Rating, Announces Price Target of $27
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Curt Woodworth has initiated coverage on Constellium (NYSE:CSTM) with a Buy rating and set a price target of $27.
January 16, 2024 | 4:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS has initiated coverage on Constellium with a Buy rating and a price target of $27, which could positively influence the stock's performance.
Analyst ratings, especially from prominent financial institutions like UBS, can significantly impact investor sentiment and stock prices. A Buy rating coupled with a price target that suggests an upside potential is likely to be viewed positively by the market, potentially leading to a short-term increase in the stock price of Constellium.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100